Spectrum Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.08M Hold
40,000
0.42% 77
2015
Q4
$1.16M Hold
40,000
0.47% 75
2015
Q3
$1.08M Hold
40,000
0.45% 77
2015
Q2
$1.09M Hold
40,000
0.42% 83
2015
Q1
$1.07M Hold
40,000
0.38% 83
2014
Q4
$846K Hold
40,000
0.29% 97
2014
Q3
$952K Hold
40,000
0.35% 88
2014
Q2
$924K Hold
40,000
0.32% 92
2014
Q1
$913K Hold
40,000
0.33% 91
2013
Q4
$739K Hold
40,000
0.26% 101
2013
Q3
$677K Hold
40,000
0.26% 100
2013
Q2
$620K Buy
+40,000
New +$666K 0.25% 103

Other funds holding NVO

Spectrum Advisory Services's NVO Position: Q1 2016 in Review

Spectrum Advisory Services held its Novo Nordisk (NVO) position steady in Q1 2016 at 40,000 shares worth $1.08M. The position accounts for 0.42% of the portfolio, ranked #77.

Spectrum Advisory Services first reported a position in NVO in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.16M in Q4 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Spectrum Advisory Services held 40,000 shares of Novo Nordisk worth $1.08M as of Q1 2016.
  • Spectrum Advisory Services left its Novo Nordisk share count unchanged in Q1 2016.
  • Novo Nordisk made up 0.42% of Spectrum Advisory Services's portfolio in Q1 2016, its #77 holding.
  • Spectrum Advisory Services first reported a position in Novo Nordisk in Q2 2013 and has held it in 12 quarters since.
  • Spectrum Advisory Services's Novo Nordisk position peaked at $1.16M in Q4 2015.
  • 535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.